We now have a glimpse behind the curtain of how Medicare arrives at so-called maximum fair prices of prescription drugs it ...

The Biden-era law is now in the hands of a new administration, and drugmakers are scanning the horizon for hints of a massive ...

Trump could either weaken the negotiations in a way that benefits the pharmaceutical industry, or try to achieve even deeper ...

The Trump administration’s Centers for Medicare & Medicaid Services (CMS) has signaled that it will be revamping the process ...

CMS recently issued a statement saying that it's continuing the Medicare Drug Price Negotiation Program but is leaving the door open for potential changes. Experts weighed in on what changes could be ...

The IRA measure is a good first step, but some are looking even further ahead to GLP-1 price drops to increase access.

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for older adults and people with disabilities.

By Rebecca Robbins Medicare’s prices for the blockbuster weight-loss drugs Ozempic and ... thanks to their inclusion on a list of medicines whose prices will be negotiated directly between ...

Democrats sought answers from RFK Jr. on how the Trump administration would handle Medicare price negotiations after a short ...

The savings from the new list prices for those drugs were expected to generate about $6 billion for taxpayers and $1.5 billion for Medicare enrollees. Negotiated prices for the first 10 drugs don ...